PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33440739-9	2021	17-AAG inhibited HSP90alpha and presented obvious reversal effects of Sorafenib resistance in vivo and in vitro.	Sorafenib	70-79	N-methylpurine DNA glycosylase	Homo sapiens	3-6	
33440739-10	2021	All the results emphasized that HSP90alpha plays a critical role in Sorafenib resistance under hypoxia and 17-AAG combined with Sorafenib is a promising therapy for hepatocellular carcinoma.	Sorafenib	68-77	N-methylpurine DNA glycosylase	Homo sapiens	110-113